Glenn Grossman

Commercial Analytics Executive | Epidemiology, Insights, Strategy, Forecasting and Advanced Analytics
Summary
Glenn Grossman is an Executive Director with a strong background in Commercial Analytics, specializing in leading teams and implementing advanced analytical strategies for healthcare business optimization and forecasting.
His expertise spans various aspects of the pharmaceutical lifecycle, including business development, pipeline, in-line products, and managed markets, with a focus on patient analytics and strategic insights generation.
Glenn's key skill areas include Multifunctional Portfolio Management, Advanced Epidemiologic Methods, Predictive Modeling, and Artificial Intelligence Analytics among others.
He holds a Ph.D. in Epidemiology from the University of North Carolina at Chapel Hill and has an educational background from Rutgers Prep and Tufts University.
Prior to his current role, he has held several notable positions including Senior Director of Outcomes Research at Novartis, Head of Commercial Analytics at The Medicines Company, and Global Director of Forecasting at Sanofi.
Moreover, Glenn has also contributed his expertise at Bristol-Myers Squibb in roles such as Statistician Lead and Senior Capability Manager in Epidemiology, showcasing his diverse experience in the healthcare industry.
His career has also included a role as a Healthcare Economist at Booz Allen Hamilton, further highlighting his analytical and strategic capabilities across different sectors.
Currently, he serves as a Consultant specializing in Pandemic Epidemiology Analytics, Insights & Forecasting, bringing his wealth of experience to empower healthcare clients with valuable insights for informed decision-making.